Revascularization for patients with severe coronary artery disease and left ventricular dysfunction

被引：2

作者：

Ghose T. ^{[1
]}

Thompson R.C. ^{[1
]}

机构：

[1] St. Luke's Hospital, Kansas City, MO 64111

来源：

Current Cardiology Reports | 2006年 / 8卷 / 4期

关键词：

Myocardial Perfusion Imaging; Viable Myocardium; Severe Coronary Artery Disease; Impaired Leave Ventricular Function; Severe Leave Ventricular;

D O I：

10.1007/s11886-006-0055-5

中图分类号：

学科分类号：

摘要：

Heart failure is becoming increasingly prevalent, and currently coronary artery disease (CAD) is the primary cause of left ventricular (LV) systolic dysfunction. A potential therapeutic option for patients with severe CAD and LV dysfunction is a strategy of revascularization. In this review, we summarize the available literature regarding revascularization for these patients. The literature suggests that patients with severe CAD and LV dysfunction may benefit from revascularization and those patients with viable myocardium may derive the most benefit. Copyright © 2006 by Current Science Inc.

引用

页码：255 / 260

页数：5

共 18 条

[1]

Chareonthaitawee P., Gersh B.J., Araoz P.A., Et al., Revascularization in severe left ventricular dysfunction: The role of viability testing, J Am Coll Cardiol, 46, pp. 567-574, (2005)

[2]

Eleven-year survival in the veterans administration randomized trial of coronary bypass surgery for stable angina, N Engl J Med, 311, pp. 1333-1339, (1984)

[3]

Varnauskas E., Twelve-year follow-up of survival in the randomized European Coronary Surgery Study, N Engl J Med, 319, pp. 332-337, (1988)

[4]

Cleland J.G.F., Freemantle N., Ball S.G., Et al., The heart failure revascularization trial (HEART): Rationale, design and methodology, Eur J Heart Fail, 5, pp. 295-303, (2003)

[5]

Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial, N Engl J Med, 310, pp. 750-758, (1984)

[6]

Gersh B.J., Kronmal R.A., Schaff H.V., Et al., Comparison of coronary artery bypass sugery and medical therapy in patients 65 years of age or older: A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry, N Engl J Med, 313, pp. 217-224, (1985)

[7]

Passamani E., Davis K.B., Gillespie M.J., Et al., A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction, N Engl J Med, 312, pp. 1665-1671, (1985)

[8]

Baker D.W., Jones R., Hodges J., Management of heart failure: The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction, JAMA, 272, pp. 1528-1534, (1994)

[9]

Morrison D., What is the evidence for percutaneous coronary intervention or coronary artery bypass graft in ischemic cardiomyopathy?, Am Heart Hosp J, 3, pp. 175-181, (2005)

[10]

Stevens T., Kahn J.K., McCallister B.D., Et al., Safety and efficacy of percutaneous transluminal coronary angioplasty in patients with left ventricular dysfunction, Am J Cardiol, 68, pp. 313-319, (1991)

← 1 2 →